Therapeutic effects of a soluble guanylate cyclase activator, BAY 60-2770, on lower urinary tract dysfunction in mice with spinal cord injury.
detrusor overactivity
mice
soluble guanylate cyclase
spinal cord injury
urodynamics
Journal
American journal of physiology. Renal physiology
ISSN: 1522-1466
Titre abrégé: Am J Physiol Renal Physiol
Pays: United States
ID NLM: 100901990
Informations de publication
Date de publication:
01 10 2022
01 10 2022
Historique:
pubmed:
12
8
2022
medline:
17
9
2022
entrez:
11
8
2022
Statut:
ppublish
Résumé
We aimed to evaluate the effects of a soluble guanylate cyclase (sGC) activator, BAY 60-2770, on neurogenic lower urinary tract dysfunction in mice with spinal cord injury (SCI). Mice were divided into the following three groups: spinal cord intact (
Identifiants
pubmed: 35952343
doi: 10.1152/ajprenal.00105.2022
pmc: PMC9485004
doi:
Substances chimiques
4-(((4-carboxybutyl) (2- (5-fluoro-2-((4'-(trifluoromethyl) biphenyl-4-yl)methoxy)phenyl)ethyl) amino)methyl)benzoic acid
0
Benzoates
0
Biphenyl Compounds
0
Hydrocarbons, Fluorinated
0
RNA, Messenger
0
Nitric Oxide Synthase
EC 1.14.13.39
Soluble Guanylyl Cyclase
EC 4.6.1.2
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
F447-F454Subventions
Organisme : NIDDK NIH HHS
ID : R01 DK129194
Pays : United States
Références
Neurourol Urodyn. 2014 Jan;33(1):54-8
pubmed: 24292974
Nat Rev Urol. 2018 Jan;15(1):42-54
pubmed: 29133940
J Sex Med. 2011 Oct;8(10):2746-60
pubmed: 21812935
J Urol. 2005 Mar;173(3):1027-32
pubmed: 15711370
Neurourol Urodyn. 2018 Aug;37(6):1889-1896
pubmed: 29516546
Neurourol Urodyn. 2020 Nov;39(8):2120-2127
pubmed: 32816344
Prog Brain Res. 2006;152:97-115
pubmed: 16198696
Neurourol Urodyn. 2010;29(1):63-76
pubmed: 20025033
Neuroscience. 2005;131(2):499-511
pubmed: 15708491
BJU Int. 2005 Dec;96(9):1392-6
pubmed: 16287464
Pharmacol Rev. 1993 Sep;45(3):253-308
pubmed: 8248281
Neurosci Lett. 2004 Jul 15;365(1):73-7
pubmed: 15234476
Am J Physiol Renal Physiol. 2017 Sep 1;313(3):F796-F804
pubmed: 28637786
Exp Neurol. 2012 May;235(1):123-32
pubmed: 21596038
Am J Physiol Renal Physiol. 2020 Mar 1;318(3):F754-F762
pubmed: 32036697
Sci Transl Med. 2018 Oct 10;10(462):
pubmed: 30305457
J Comp Neurol. 2002 Jul 29;449(3):217-30
pubmed: 12115676
Am J Physiol Renal Physiol. 2019 Nov 1;317(5):F1305-F1310
pubmed: 31566429
Am J Physiol Renal Physiol. 2021 Jul 1;321(1):F26-F32
pubmed: 33969698
Neurourol Urodyn. 2011 Mar;30(3):292-301
pubmed: 21284024
Cell. 2014 Dec 18;159(7):1640-51
pubmed: 25525881
BJU Int. 2015 Nov;116(5):797-804
pubmed: 25109632
J Pharmacol Exp Ther. 2014 Apr;349(1):2-9
pubmed: 24421320
Life Sci. 2013 May 30;92(20-21):1024-8
pubmed: 23583569
Am J Physiol Regul Integr Comp Physiol. 2016 Apr 15;310(8):R752-8
pubmed: 26818058
Neurourol Urodyn. 2018 Feb;37(2):666-672
pubmed: 28782191
Cell Rep. 2017 Dec 5;21(10):2760-2771
pubmed: 29212024
Nat Commun. 2020 Jun 19;11(1):2997
pubmed: 32561714
Pharmacol Rev. 1991 Jun;43(2):109-42
pubmed: 1852778
Physiol Rep. 2018 Sep;6(17):e13858
pubmed: 30175474
Exp Neurol. 2000 Jan;161(1):273-84
pubmed: 10683293
J Urol. 2010 Aug;184(2):769-74
pubmed: 20639054
Life Sci. 2021 Dec 1;286:120001
pubmed: 34614417
Nat Neurosci. 2015 Jan;18(1):10-6
pubmed: 25469543
Neurourol Urodyn. 2017 Jun;36(5):1301-1305
pubmed: 27778376